Kiwi Wealth Investments Limited Partnership’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Kiwi Wealth Investments Limited Partnership's BMY Position: Q3 2023 in Review
Kiwi Wealth Investments Limited Partnership sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 219,210 shares — an estimated $14M sold.
Kiwi Wealth Investments Limited Partnership first reported a position in BMY in Q3 2019 and held it in 10 quarters. The position peaked at $17.9M in Q4 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Kiwi Wealth Investments Limited Partnership reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- Kiwi Wealth Investments Limited Partnership sold 219,210 Bristol-Myers Squibb shares in Q3 2023, an estimated $14M.
- Kiwi Wealth Investments Limited Partnership first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 10 quarters.
- Kiwi Wealth Investments Limited Partnership's Bristol-Myers Squibb position peaked at $17.9M in Q4 2022.
- 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q3 2023, filed 14 Nov 2023.